Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

179.20 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
72 73 Next >
3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates
These three dividend stocks have proved themselves to be among the best Dividend Aristocrats to buy for high-growth returns. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Top 7 Dividend Stocks to Buy in March 2024
Bet on these top dividend stocks to buy for a resilient income flow and steady market gains, offering excellent balance. 
Via InvestorPlace
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
Here are seven dividend kings that manage to deliver market-beating stock price growth in addition to their reliable, growing dividends. 
Via InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Is AbbVie Stock a Buy Now?
Some would say the growth story is over, but that view might be a bit myopic. 
Via The Motley Fool
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
The Hot List: 3 AI Stocks Worth Buying on Weakness
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Better Dividend Growth Stock: AbbVie or Amgen?
A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy. 
Via The Motley Fool
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Friday Morning
Via Investor Brand Network
AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
A Relative Strength Rating upgrade for AbbVie shows improving technical performance. 
Via Investor's Business Daily
AbbVie Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
From FN Media Group LLC
Via GlobeNewswire
Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea
From Healis Therapeutics
Via GlobeNewswire
3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade
These stocks don't offer the highest yields, but their payouts are growing fast. 
Via The Motley Fool
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more. 
Via Benzinga
3 Dividend Stocks That Are No-Brainer Buys Right Now
These stocks check off multiple boxes for investors. 
Via The Motley Fool
Is AbbVie Stock a Buy Now?
Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable. 
Via The Motley Fool
5 Forever Dividend Stocks to Build Your Portfolio
These five stocks are high quality and reliable. 
Via The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. 
Via The Motley Fool
3 Cash Cows to Boost Your Confidence During the February Chill
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns. 
Via InvestorPlace
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END 
Via FinancialNewsMedia
Beyond Nvidia: How To Navigate Investing In Your 40s — Insights From Reddit
A Reddit user reached out to the community seeking advice beyond the hunt for the "next NVIDIA Corp." Here's a sample of the responses. 
Via Benzinga
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
From FN Media Group LLC
Via GlobeNewswire
The 7 Best Momentum Stocks You Can Purchase Today
If you’re looking for hot opportunities in the market, here are just a few of the best momentum stocks to buy today. 
Via InvestorPlace
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
These incredible businesses have long histories of successes behind them, and more to come. 
Via The Motley Fool
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy
The drugmaker is handling its biggest obstacle yet relatively well. 
Via The Motley Fool
Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all... 
Via Benzinga
3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying?
Letting your winners run is a proven way to generate extraordinary portfolio returns without cutting them off by taking profits. 
Via InvestorPlace
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
72 73 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.